SHALBY Stock Overview
Engages in the operation of multi-specialty hospitals primarily in India, the United States, Japan, Indonesia, Oman, the United Arab Emirates, Bangladesh, Nepal, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Shalby Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹225.53 |
| 52 Week High | ₹339.50 |
| 52 Week Low | ₹204.05 |
| Beta | 1.14 |
| 1 Month Change | 1.26% |
| 3 Month Change | -19.71% |
| 1 Year Change | -24.94% |
| 3 Year Change | 57.66% |
| 5 Year Change | 156.28% |
| Change since IPO | -5.87% |
Recent News & Updates
Recent updates
Does Shalby (NSE:SHALBY) Have A Healthy Balance Sheet?
Nov 05
Market Cool On Shalby Limited's (NSE:SHALBY) Earnings Pushing Shares 26% Lower
Mar 14These 4 Measures Indicate That Shalby (NSE:SHALBY) Is Using Debt Reasonably Well
Nov 22Is Now The Time To Look At Buying Shalby Limited (NSE:SHALBY)?
Nov 01We Like These Underlying Return On Capital Trends At Shalby (NSE:SHALBY)
Sep 06Returns On Capital At Shalby (NSE:SHALBY) Have Stalled
Jan 01Shalby (NSE:SHALBY) Is Due To Pay A Dividend Of ₹1.00
Sep 11Shalby (NSE:SHALBY) Is Due To Pay A Dividend Of ₹1.00
Aug 28Shalby (NSE:SHALBY) Will Be Hoping To Turn Its Returns On Capital Around
Aug 19Is Shalby (NSE:SHALBY) Using Too Much Debt?
Jun 21Returns On Capital At Shalby (NSE:SHALBY) Paint A Concerning Picture
Apr 06Here's Why We Think Shalby (NSE:SHALBY) Is Well Worth Watching
Feb 25Why Shalby Limited (NSE:SHALBY) Could Be Worth Watching
Jun 30Shalby (NSE:SHALBY) Will Will Want To Turn Around Its Return Trends
May 12Shalby (NSE:SHALBY) Has A Pretty Healthy Balance Sheet
Mar 30Is Now The Time To Look At Buying Shalby Limited (NSE:SHALBY)?
Mar 16Shareholder Returns
| SHALBY | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 1.8% | -0.7% | 0.2% |
| 1Y | -24.9% | 37.3% | 17.2% |
Return vs Industry: SHALBY underperformed the Indian Healthcare industry which returned 37.3% over the past year.
Return vs Market: SHALBY underperformed the Indian Market which returned 17.2% over the past year.
Price Volatility
| SHALBY volatility | |
|---|---|
| SHALBY Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: SHALBY has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: SHALBY's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 2,853 | Vikram Shah | www.shalby.org |
Shalby Limited engages in the operation of multi-specialty hospitals primarily in India, the United States, Japan, Indonesia, Oman, the United Arab Emirates, Bangladesh, Nepal, and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers arthroscopy, arthroplasty, cardiology, vascular surgery, cardiothoracic and cardiac rehabilitation, cosmetic and aesthetic, dental cosmetic and implantology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver transplant, dermatology, psychiatry, urology, anesthesia, and hip and knee joint replacement services.
Shalby Limited Fundamentals Summary
| SHALBY fundamental statistics | |
|---|---|
| Market cap | ₹24.24b |
| Earnings (TTM) | ₹547.18m |
| Revenue (TTM) | ₹10.07b |
44.3x
P/E Ratio2.4x
P/S RatioIs SHALBY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHALBY income statement (TTM) | |
|---|---|
| Revenue | ₹10.07b |
| Cost of Revenue | ₹7.61b |
| Gross Profit | ₹2.46b |
| Other Expenses | ₹1.91b |
| Earnings | ₹547.18m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.09 |
| Gross Margin | 24.39% |
| Net Profit Margin | 5.44% |
| Debt/Equity Ratio | 40.1% |
How did SHALBY perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield25%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 00:47 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shalby Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Siddhant Khandekar | ICICIdirect.com |